Characterization of preclinical radio ADME properties of ARV-471 for predicting human PK using PBPK modeling

Proteolysis-targeting chimeras (PROTACs) represent a promising class of drugs that can target disease-causing proteins more effectively than traditional small molecule inhibitors can, potentially revolutionizing drug discovery and treatment strategies. However, the links between in vitro and in vivo...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yifei He, Chenggu Zhu, Peng Lei, Chen Yang, Yifan Zhang, Yuandong Zheng, Xingxing Diao
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2025-05-01
Series:	Journal of Pharmaceutical Analysis
Assuntos:	PROTAC Vepdegestrant (ARV-471) Radiolabeling In vitro–in vivo extrapolation (IVIVE) Physiologically based pharmacokinetic (PBPK) model
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2095177924002727
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!